Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
Text Size
8 studies found for:    19745216 [PUBMED-IDS]

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Completed Differences in Response to the Flu Vaccine Among Adults With HIV and Without HIV in Uganda
Conditions: HIV;   Acquired Immunodeficiency Syndrome;   Influenza
Intervention: Drug: Seasonal trivalent inactivated influenza vaccine (Vaxigrip®)
2 Completed Evaluation of Influenza H1N1 Vaccine in Adults With Lymphoid Malignancies on Chemotherapy
Conditions: Lymphoma;   Multiple Myeloma;   Influenza A Virus, H1N1 Subtype
Intervention: Biological: AS03-adjuvanted H1N1 pandemic influenza vaccine
3 Terminated Effect of Age and Prior Immunity on Response to H1N1 Vaccines in Children
Condition: 2009 H1N1 Influenza
Interventions: Biological: Live Attenuated H1N1 Influenza Vaccine;   Biological: Influenza A (H1N1) 2009 Monovalent Vaccine;   Biological: Influenza A (H1N1) 2009 Monovalent Vaccine/ Influenza A (H1N1) Monovalent Vaccine Live
4 Unknown † Effect of Age and Prior Immunity to Response to Seasonal Influenza Vaccines in Children
Condition: Influenza
Interventions: Biological: Trivalent Seasonal Live attenuated Influenza vaccine;   Biological: Seasonal Trivalent Influenza Vaccine 2010-2011;   Biological: Seasonal Influenza Vaccine TIV/LAIV;   Biological: Seasonal Influenza Vaccines LAIV/TIV
5 Unknown † Basic and Clinical Research on Applying Blood Fix to Treat Critical H1N1 Patients
Conditions: Virus Diseases;   Respiratory Tract Diseases;   Respiratory Tract Infections;   Influenza;   Orthomyxoviridae Infections
Interventions: Biological: split-virion, non-adjuvanted H1N1 vaccine of 15 μg;   Other: blood fix
6 Completed Immunologic Response After Pandemic Influenza A (H1N1) Vaccine in Onco- Hematologic Patients
Conditions: Lymphoma;   Multiple Myeloma;   Myeloproliferative Disease
Intervention: Biological: Reassortant vaccine virus NYMC X-179A (New York Medical College, New York) derived form the A/california/7/2009 (H1N1) virus
7 Completed
Has Results 		A Clinical Trial of CSL's 2009 H1N1 Influenza Vaccine (CSL425) in Healthy Adults
Condition: Influenza Caused by the Novel Influenza A (H1N1) Virus
Intervention: Biological: CSL425
8 Completed Effects of Age on Response to the 2009 H1N1 Virus Vaccine
Condition: 2009 H1N1 Influenza Virus
Intervention: Biological: 2009 H1N1 Virus Vaccine
To Top

† Indicates status has not been verified in more than two years